2023
DOI: 10.3389/frobt.2022.1068413
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of movement disorders using wearable sensors during upper limb tasks: A scoping review

Abstract: Background: Studies aiming to objectively quantify movement disorders during upper limb tasks using wearable sensors have recently increased, but there is a wide variety in described measurement and analyzing methods, hampering standardization of methods in research and clinics. Therefore, the primary objective of this review was to provide an overview of sensor set-up and type, included tasks, sensor features and methods used to quantify movement disorders during upper limb tasks in multiple pathological popu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 166 publications
0
12
0
Order By: Relevance
“…To address the challenges of dystonia assessment, researchers have explored various instrumented solutions, such as electromyography [7] or body-worn sensors [19]. However, the successful integration of these approaches into clinical practice has proven elusive [20].…”
Section: Introductionmentioning
confidence: 99%
“…To address the challenges of dystonia assessment, researchers have explored various instrumented solutions, such as electromyography [7] or body-worn sensors [19]. However, the successful integration of these approaches into clinical practice has proven elusive [20].…”
Section: Introductionmentioning
confidence: 99%
“…3) on the gyroscope data of the x-axis may have in uenced the image generation and affected the accuracy. In future work, it is important to extract relevant features that can identify straight and turning gait patterns in the 6MWT from the domains of bilateral coordination, asymmetry, truncal symptom severity, and variability by performing non-linear analysis, and then use machine learning techniques to analyze speci c biomarkers associated with early-stage PD [54]. Finally, we only considered patients with early H&Y-stage PD; however, patients with severe symptoms may differ from those analyzed herein.…”
Section: Discussionmentioning
confidence: 99%
“…Objective assessments of the listed symptoms have been developed and tested for many years, but the validation of continuous measures throughout a day against a gold standard assessment is often limited ( Sica et al, 2021 ; Vanmechelen et al, 2022 ). Some IMU-based proprietary methods reported good correlations of passively generated symptom assessments and traditional gold standard assessments on larger temporal intervals ( Guan et al, 2021 ; Rodríguez-Martín et al, 2022 ).…”
Section: Current Literaturementioning
confidence: 99%